167 related articles for article (PubMed ID: 29337063)
1. BMI1 activates WNT signaling in colon cancer by negatively regulating the WNT antagonist IDAX.
Yu F; Zhou C; Zeng H; Liu Y; Li S
Biochem Biophys Res Commun; 2018 Feb; 496(2):468-474. PubMed ID: 29337063
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer.
Yu T; Chen X; Zhang W; Colon D; Shi J; Napier D; Rychahou P; Lu W; Lee EY; Weiss HL; Evers BM; Liu C
J Biol Chem; 2012 Feb; 287(6):3760-8. PubMed ID: 22170051
[TBL] [Abstract][Full Text] [Related]
3. A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway.
Cho JH; Dimri M; Dimri GP
J Biol Chem; 2013 Feb; 288(5):3406-18. PubMed ID: 23239878
[TBL] [Abstract][Full Text] [Related]
4. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract.
Tateishi K; Ohta M; Kanai F; Guleng B; Tanaka Y; Asaoka Y; Tada M; Seto M; Jazag A; Lianjie L; Okamoto M; Isayama H; Tada M; Yoshida H; Kawabe T; Omata M
Clin Cancer Res; 2006 Dec; 12(23):6960-6. PubMed ID: 17145814
[TBL] [Abstract][Full Text] [Related]
6. Sam68/KHDRBS1 is critical for colon tumorigenesis by regulating genotoxic stress-induced NF-κB activation.
Fu K; Sun X; Wier EM; Hodgson A; Liu Y; Sears CL; Wan F
Elife; 2016 Jul; 5():. PubMed ID: 27458801
[TBL] [Abstract][Full Text] [Related]
7. LGR5 and BMI1 Increase Pig Intestinal Epithelial Cell Proliferation by Stimulating WNT/β-Catenin Signaling.
Li XG; Wang Z; Chen RQ; Fu HL; Gao CQ; Yan HC; Xing GX; Wang XQ
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29601474
[TBL] [Abstract][Full Text] [Related]
8. Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.
Jian Y; Wang M; Zhang Y; Ou R; Zhu Z; Ou Y; Chen X; Liang X; Ding Y; Song L; Xu X; Liao W
Cancer Lett; 2018 Aug; 428():1-11. PubMed ID: 29660380
[TBL] [Abstract][Full Text] [Related]
9. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
Griffith J; Andrade D; Mehta M; Berry W; Benbrook DM; Aravindan N; Herman TS; Ramesh R; Munshi A
Oncol Rep; 2017 Apr; 37(4):2382-2390. PubMed ID: 28260023
[TBL] [Abstract][Full Text] [Related]
10. MUC1-C activates BMI1 in human cancer cells.
Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
[TBL] [Abstract][Full Text] [Related]
11. A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition.
Gisler S; Maia ARR; Chandrasekaran G; Kopparam J; van Lohuizen M
PLoS One; 2020; 15(4):e0227592. PubMed ID: 32343689
[TBL] [Abstract][Full Text] [Related]
12. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.
Kim HY; Park JH; Won HY; Lee JY; Kong G
FASEB J; 2015 Jan; 29(1):300-13. PubMed ID: 25351982
[TBL] [Abstract][Full Text] [Related]
13. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
M JR; S V
Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
[TBL] [Abstract][Full Text] [Related]
14. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
Gergely JE; Dorsey AE; Dimri GP; Dimri M
Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p.
Ma MZ; Chu BF; Zhang Y; Weng MZ; Qin YY; Gong W; Quan ZW
Cell Death Dis; 2015 Jan; 6(1):e1583. PubMed ID: 25569100
[TBL] [Abstract][Full Text] [Related]
16. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
Neri F; Dettori D; Incarnato D; Krepelova A; Rapelli S; Maldotti M; Parlato C; Paliogiannis P; Oliviero S
Oncogene; 2015 Aug; 34(32):4168-76. PubMed ID: 25362856
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer.
Guo Y; Wang M; Jia X; Zhu H; Zhi Y; Yuan L
Oncol Rep; 2018 Aug; 40(2):1165-1173. PubMed ID: 29901158
[TBL] [Abstract][Full Text] [Related]
18. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
[TBL] [Abstract][Full Text] [Related]
19. Bmi1 Regulates the Proliferation of Cochlear Supporting Cells Via the Canonical Wnt Signaling Pathway.
Lu X; Sun S; Qi J; Li W; Liu L; Zhang Y; Chen Y; Zhang S; Wang L; Miao D; Chai R; Li H
Mol Neurobiol; 2017 Mar; 54(2):1326-1339. PubMed ID: 26843109
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of polycomb-group RING finger 6 modulates mouse male germ cell differentiation in vitro.
Sun J; Wang J; He L; Lin Y; Wu J
Cell Physiol Biochem; 2015; 35(1):339-52. PubMed ID: 25591775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
